Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • An Unforgettable Evening: EO Noida’s 4th President’s Gala Shines Bright Business
  • Care Edge Ratings Assigned Credit Ratings to Utssav CZ Gold Jewels Limited Business
  • Uplift the Girls Empower the Women- Saubhagyaa R Swain Press Release
  • Praveg Limited Secures Prestigious Government Mandate for Sardar Patel at 150th Unity March – Pad Yatra Business
  • FOSTTA Celebrates “World Saree Day” Lifestyle
  • BalanceGurus Provides A Free Platform To Wellness Centers And Retreats To List Their Ventures Lifestyle
  • From selling notes for paying his college fees to become India’s First Laserpreneur, here is the story of the Pioneer of Laser Dentistry in India! Lifestyle
  • Badthameez Store offers 10% discount on the first order Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • National CSR Network Launches Capacity Building on CSR Competency Framework Business
  • YES WORLD Now Holds a World Record Business
  • KRN Heat Exchanger’s Neemrana Facility Receives Rs 182.95 Cr Incentive from Rajasthan Government Business
  • CII hosts the 2nd Manufacturing Excellence Summit Business
  • Indiabulls Says Rs. 8,268 Crore Loans Fully Repaid; EOW Report Finds No Financial Loss in Key Borrower Groups Business
  • VMS TMT Reports Robust Q3 FY26 with 43pc EBITDA Growth and 278pc PAT Increase QoQ Business

Recent Posts

  • Investment Migration Draws A Wider Pool Of Indian Applicants
  • OPPO Gujarat Hosts ‘Diwali Unplugged’ – Celebrating Creativity, Connections and Festivity along with Oppo FindX 10 Series
  • GYFTR: India’s Gift Card King Is Just Getting Started
  • HOAC Foods India Limited Reports Strong H1 FY27 Results
  • Captain Polyplast Limited Reports Robust Q2 & H1 FY27 Growth, with Total Income Rising 32.89% & 25.14%, Respectively

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • NHC Foods Signs Mou With Lotmor Brands, Eyes Diversification, Retail Growth, Appoints New KMPs Business
  • From designing banner to making films, Abdallah Darabseh has came a long way Lifestyle
  • Tata Salt Encourages Kids of Ahmedabad to Ask Questions for the Nation Business
  • AVIRAL 2026: Titiksha Public School Showcases Sporting Talent and Excellence Lifestyle
  • Kaveesha Verma and Sushama win in Premium Beauty Pageant Glam Guidance Miss/Mrs India Universe 2022 in their categories Lifestyle
  • Bartan Bank Revolution: An Innovative Step Towards a Green India National
  • AZAD Engineering Inaugurates Exclusive Lean Manufacturing Facility for Siemens Energy Business
  • 6.5 Lakh Early Exits, 25,000 Cool-Off Users Mark Shift to Responsible Opinion Trading on Probo Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme